Hospital Universitario Niño Jesús Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2017
NCT03275818
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Hospital Universitario Niño Jesús

Active Ingredients

Drugs in Phase 2 Trials (1)

paclitaxel (taxol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Desmoplastic Small Round Cell Tumor (Phase 2)

Fibromatosis, Aggressive (Phase 2)

Neoplasms (Phase 2)

Neuroectodermal Tumors, Primitive, Peripheral (Phase 2)

Sarcoma (Phase 2)

Sarcoma, Ewing (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1